Four European countries—Italy, Russia, Sweden, and the United Kingdom—reported their first novel coronavirus (2019-nCoV) cases today, as the unprecedented surge of illnesses continues in China and the outbreak grows outside of China, along with more reports of local transmission.
In another major development today, Gilead today announced that it is working with China on the launch of a trial to assess if its antiviral remdesivir can be used to treat 2019-nCoV infections.
Global cases today approached 10,000, including 213 deaths, all in China.
Virus extends reach in Europe
Credit CDC
Read more at CIDRAP…
See also:
Jan 31 Italian health ministry statement
Jan 31 Russian government statement
Jan 31 Swedish Public Health Authority statement
Jan 31 UK statement
Jan 31 BBC report
Jan 31 China CDC update
Chinese medical community (DXY) 2019-nCoV tracking website
Jan 31 Hong Kong CHP statement
Jan 31 Gilead press release
Jan 31 N Engl J Med case report
Jan 31 Deutsche Welle story
Jan 31 Reuters story
Jan 31 Japanese health ministry statement on latest local spread case
Jan 31 Japanese health ministry statement on asymptomatic evacuees
Jan 31 AFD post
Jan 31 Toronto Public Health statement
Jan 31 Singapore health ministry statement
Jan 31 KCDC statement
The post nCoV expands in Europe; antiviral drug study to launch in China appeared first on Healthier Environment Living Program.